Nialamide
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
N-benzyl-3-(N'-(pyridine-4-carbonyl)hydrazino)propanamide
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 51-12-7 Y |
ATC code | N06AF02 (WHO) |
PubChem | CID: 4472 |
DrugBank | DB04820 Y |
ChemSpider | 4317 Y |
UNII | T2Q0RYM725 Y |
KEGG | D07337 Y |
Chemical data | |
Formula | C16H18N4O2 |
Molecular mass | 298.34 g/mol |
|
|
|
|
(verify) |
Nialamide (Niamid, Niamide, Nuredal, Surgex) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant.[1] It was withdrawn by Pfizer several decades ago due to the risk of hepatotoxicity.[2][3]
See also
References
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
<templatestyles src="Asbox/styles.css"></templatestyles>
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://infogalactic.com/w/index.php?title=Nialamide&oldid=779259"
Hidden categories: